Preterm Birth and PROM Testing Market By Test Type (Diagnostic Tests, Screening Tests, Home Test Kits), By Application (Preterm Birth Detection, Preterm Rupture of Membranes (PROM) Detection, Pregnancy Complications Screening), By Distribution Channel (Retail Pharmacies, Online Sales, Medical Device Distributors, Hospitals), By End-User (Hospitals, Diagnostic Labs, Home Care Providers, Gynecology Clinics), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Preterm Birth and PROM Testing Market was valued at USD 1.5 billion in 2024-e and will surpass USD 2.3 billion by 2030; growing at a CAGR of 7.9% during 2025 - 2030.

The preterm birth and preterm rupture of membranes (PROM) testing market is growing rapidly as maternal health continues to be a critical focus within the healthcare sector. Preterm birth, defined as a birth that occurs before 37 weeks of gestation, and PROM, the premature rupture of amniotic membranes before labor begins, are two significant complications during pregnancy that can lead to adverse outcomes for both the mother and the baby. Early detection of these conditions is crucial for providing timely interventions that can improve pregnancy outcomes. As awareness of these risks increases, there is a rising demand for diagnostic, screening, and home test kits designed to detect these complications early.

Technological advancements in test kits, along with the growing trend toward home-based care, are shaping the market landscape. Diagnostic tests and home test kits are designed to provide accurate and quick results, helping healthcare providers and patients monitor and manage potential risks during pregnancy. The increasing prevalence of preterm births, combined with a push for more accessible, cost-effective, and non-invasive testing methods, is driving the demand for these tests, particularly in hospitals, diagnostic labs, and home care settings. These trends are expected to fuel the continued expansion of the preterm birth and PROM testing market.

Diagnostic Tests Segment is Largest Owing to Accuracy and Early Detection Capabilities

The diagnostic tests segment is the largest within the preterm birth and PROM testing market, driven by the accuracy and early detection capabilities that these tests provide. Diagnostic tests play a critical role in identifying preterm birth risks and PROM at an early stage, enabling healthcare providers to take immediate action to reduce complications. These tests are often used in hospitals and diagnostic laboratories, where they can be administered under controlled conditions with results that guide clinical decisions. Diagnostic tests for preterm birth and PROM typically involve detecting specific biomarkers or using imaging techniques to assess the condition of the amniotic sac and cervix.

The accuracy of diagnostic tests is particularly important in managing high-risk pregnancies. For example, tests that detect fetal fibronectin or measure cervical length are crucial in determining the likelihood of preterm labor, helping healthcare professionals plan appropriate interventions. As the focus on maternal and fetal health intensifies, the demand for these precise and reliable tests is expected to grow, with hospitals and diagnostic labs continuing to be the primary users. The advancements in diagnostic technology are enhancing the overall effectiveness and ease of use, contributing to the expansion of this segment within the market.

Home Test Kits Segment is Fastest Growing Owing to Convenience and At-Home Monitoring

The home test kits segment is the fastest growing in the preterm birth and PROM testing market, driven by the increasing preference for convenience and at-home monitoring. Home test kits offer expectant mothers the ability to monitor signs of preterm birth or PROM without needing to visit a healthcare facility. These kits are easy to use, provide quick results, and allow women to take proactive steps if complications arise, such as consulting a healthcare provider if test results indicate a risk. Home test kits for detecting PROM typically use a simple urine-based test that detects the presence of amniotic fluid, providing valuable information on whether a woman is at risk of early labor.

The growing demand for home healthcare solutions is spurring innovation in home test kits, with manufacturers focusing on improving accuracy, ease of use, and reliability. As more women seek to manage their pregnancies from the comfort of their homes, home test kits are becoming an increasingly popular choice, particularly for early screening. This trend is expected to continue as awareness of preterm birth and PROM risks rises, and as more women take an active role in monitoring their health during pregnancy. The growth of this segment reflects a shift toward more personalized, convenient healthcare options in the maternal care market.

Hospitals Segment is Largest End-User Owing to High Demand for Accurate Testing in High-Risk Pregnancies

The hospitals segment is the largest end-user in the preterm birth and PROM testing market, owing to the high demand for accurate testing and monitoring in high-risk pregnancies. Hospitals are the primary settings for diagnosing and managing pregnancy complications, including preterm birth and PROM. The advanced medical equipment available in hospitals, coupled with trained healthcare professionals, ensures that testing is performed accurately and promptly. In high-risk pregnancies, early detection of these conditions is crucial to prevent preterm births and the associated complications, which is why hospitals are the largest consumers of diagnostic and screening tests for preterm birth and PROM.

Hospitals typically use a combination of diagnostic tests and screening methods to monitor at-risk pregnancies and provide timely interventions. The growing focus on maternal health and improved pregnancy outcomes is driving the demand for these tests in hospital settings, ensuring that the hospitals segment remains dominant. Furthermore, the ability to conduct comprehensive testing and follow-up care in hospitals continues to make them the preferred choice for high-risk pregnancies, reinforcing the importance of this end-user category in the overall market.

Retail Pharmacies Segment is Fastest Growing Distribution Channel Owing to Easy Access and Home Care Preferences

The retail pharmacies segment is the fastest growing distribution channel in the preterm birth and PROM testing market, driven by the increasing demand for easy access to diagnostic tools and home monitoring solutions. Retail pharmacies are playing a growing role in distributing home test kits for preterm birth and PROM detection, offering expectant mothers the convenience of purchasing these tests at nearby locations. With more women seeking to monitor their pregnancies from home, retail pharmacies are becoming key distributors of at-home test kits, which provide a simple and non-invasive way to detect complications early.

In addition to home test kits, retail pharmacies are also contributing to the availability of over-the-counter screening tests for pregnancy-related conditions. The increased availability of these products in retail settings, combined with the growing trend toward home healthcare, is fueling the segment's growth. The retail pharmacies channel is expected to continue to expand as more women turn to accessible, cost-effective testing options for early detection and monitoring of preterm birth and PROM risks during pregnancy.

Preterm Birth Detection Application Segment is Largest Owing to High Incidence and Early Risk Detection Needs

The preterm birth detection application segment is the largest in the preterm birth and PROM testing market, driven by the high incidence of preterm births and the critical need for early risk detection. Preterm birth is a leading cause of neonatal morbidity and mortality, which makes early detection essential for improving outcomes for both the mother and the baby. Tests that detect biomarkers indicating the risk of preterm birth, such as fetal fibronectin or cervical length measurements, are widely used to identify women at risk and enable early interventions, such as progesterone treatment or cervical cerclage, to prevent preterm labor.

As the number of preterm births remains a global concern, the demand for effective screening and diagnostic tests to detect early signs of labor is expected to remain high. The ability to identify women at risk for preterm birth early in pregnancy is crucial for managing complications and reducing adverse outcomes. This has made preterm birth detection the dominant application in the market, with hospitals and diagnostic laboratories driving the demand for these tests.

North America is Largest Region Owing to Advanced Healthcare Systems and High Prevalence of Preterm Birth

North America is the largest region in the preterm birth and PROM testing market, owing to the advanced healthcare systems, high prevalence of preterm birth, and growing awareness about maternal health. The United States, in particular, has a well-developed healthcare infrastructure and widespread access to diagnostic tests, both in healthcare facilities and through retail pharmacies. The high prevalence of preterm birth in the region, along with the increasing focus on improving maternal and neonatal health outcomes, is driving demand for preterm birth and PROM testing solutions.

Additionally, North America is home to a significant number of healthcare companies that are developing and commercializing innovative testing solutions, which further supports the region’s dominance in the market. With ongoing advancements in diagnostic technologies and an increasing preference for home testing options, North America is expected to remain the leading market for preterm birth and PROM testing in the coming years.

Competitive Landscape

The preterm birth and PROM testing market is highly competitive, with several key players focusing on developing accurate, reliable, and convenient testing solutions. Major companies in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Hologic, which are well-established providers of diagnostic tests and screening solutions for pregnancy-related complications. These companies are constantly innovating to improve the accuracy and ease of use of their products, as well as expanding their product portfolios to meet the growing demand for home test kits and non-invasive diagnostic options.

In addition to these large players, smaller, specialized companies are emerging in the market, offering innovative solutions targeted at specific aspects of pregnancy monitoring. With the rising demand for home-based healthcare, the competition is intensifying, with companies focusing on product differentiation, ease of use, and affordability to maintain a competitive edge. As the market continues to grow, the competitive landscape is expected to evolve, with advancements in testing technology and a shift toward personalized healthcare solutions driving innovation in the preterm birth and PROM testing market.

List of Leading Companies:

• Hologic
• Abbott Laboratories
• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• Siemens Healthineers
• Bio-Rad Laboratories
• Becton, Dickinson and Company
• Quidel Corporation
• GE Healthcare
• PerkinElmer
• Natera
• Fujifilm Holdings Corporation
• Medtronic
• Philips Healthcare
• Beckman Coulter

Recent Developments:

• In December 2024, Hologic launched an innovative test kit for the early detection of preterm birth biomarkers.
• In November 2024, Abbott Laboratories announced the approval of a new blood test to diagnose PROM with higher accuracy.
• In October 2024, F. Hoffmann-La Roche introduced an advanced screening test that can detect preterm labor risk at an early stage.
• In September 2024, Siemens Healthineers unveiled a new diagnostic device for rapid PROM testing, providing real-time results in clinics.
• In August 2024, Thermo Fisher Scientific expanded its product range to include a home-use PROM test kit, increasing convenience for expectant mothers.

Report Scope: